Latest news with #Azurion
Yahoo
30-07-2025
- Health
- Yahoo
Philips to deploy image-guided therapy systems across Indonesia
Health technology company Royal Philips has joined forces with Indonesia's Ministry of Health to implement image-guided therapy systems across the country. This endeavour is part of the Strengthening Indonesia's Healthcare Referral Network (SIHREN) project, which aims to boost treatment for heart disease, stroke, and cancer. Royal Philips CEO Roy Jakobs said: "Delivering better care for more people requires strong partnerships and the best innovations. 'We're honoured to be Indonesia's partner of choice to deliver our innovation directly where it's needed most. More patients in Indonesia will now have access to better care.' The agreements, resulting from an international bidding process, encompass treatment technology, services, and training to fortify the health infrastructure of Indonesia. Funded by the World Bank and other multilateral development banks, the SIHREN project supports the health transformation agenda of the country by enhancing referral healthcare services. The project is set to increase access to minimally invasive treatments in hundreds of hospitals throughout 38 provinces, developing a network of image-guided therapy rooms. The Indonesian Ministry of Health is focused on providing nationwide coverage of the Azurion platform, tailored to the requirements of local hospital infrastructures and patient populations. Philips' chief medical officer Carla Goulart Peron said: 'Minimally invasive care is life-changing for patients, unlocking treatment options that were once unimaginable. With small incisions, such targeted treatments can mean shorter hospital stays, fewer complications and quicker recoveries for patients. 'From opening heart-attack-causing blockages, to treating strokes and targeting cancer tumours, image-guided, minimally invasive therapy will be a game-changer for NCD [non-communicable diseases] care in Indonesia.' Philips has more than 3,900 employees in 12 Indonesian cities and operates a manufacturing facility in Batam for its Personal Health businesses. Recently, the Philips Foundation collaborated with World Child Cancer to promote early detection of childhood cancers in Indonesia. Philips Indonesia president director Astri R Dharmawan said: 'We remain committed to supporting healthcare transformation by delivering innovations that provide better outcomes for patients and improve the experience for healthcare workers. 'Our combined efforts with the Indonesian government will help close healthcare gaps and bring us closer to a Healthy Indonesia.' In October 2024, Philips collaborated with Indonesia's Siloam Hospitals Group to accelerate AI capabilities and advance the country's healthcare sector. "Philips to deploy image-guided therapy systems across Indonesia" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
RTÉ News
29-07-2025
- Business
- RTÉ News
Philips sees tariffs impact of €150-200m after US-EU deal
Dutch healthcare technology company Philips has today lowered its estimated impact from import tariffs after the US and the European Union agreed to the US imposing a 15% rate on most EU goods. The group, which sells products ranging from toothbrushes to medical imaging systems, said it expects an impact of €150-200m from the tariffs, lower than the €250-300m it estimated previously. The tariff impact "has evolved and continues to be dynamic", Philips said in a statement. The company also increased its core profit (EBITA) margin forecast to a range between 11.3% and 11.8% from its previous forecast of 10.8%-11.3%. Its second-quarter adjusted EBITA margin grew to 12.4%, beating analysts' average forecast of 9.9% in a company-provided consensus, while sales were in line with expectations at €4.3 billion. Philips operates through its Personal Health, Diagnosis & Treatment, and Connected Care segments. Its top selling products include image-guided and diagnostic systems, consumer electronics and appliances. The company said its comparable order intake grew by 6% in the quarter, citing the impact of innovations including AI-enabled diagnostic systems. The group also said it had signed a long-term deal with the Indonesian Ministry of Health for its Azurion image-guided therapy system for cardiac, stroke and cancer care.
Mint
29-07-2025
- Business
- Mint
Philips Soars After Lifting Margin Outlook on Softer Tariff Hit
(Bloomberg) -- Royal Philips NV increased its profitability outlook as the impact of the trade war was not as severe as it feared. The Dutch medical-technology firm now expects full-year adjusted operating earnings margin of as much as 11.8%, a 50 basis points increase from its previous outlook, according to a statement Tuesday. Shares in Philips rose 14% in early trading in Amsterdam, the biggest intraday advance in a year. 'It's a combination of the strong performance plus tariffs that led to a change in guidance,' Chief Executive Officer Roy Jakobs said in an interview. The MRI and ultrasound machine maker's second-quarter sales increased 0.6% to €4.3 billion ($4.98 billion), compared with estimates for a 0.5% contraction in a Bloomberg survey. 'Overall, we see this as a positive release for Philips with improving underlying performance at the company testament to some of the turnaround actions taken,' Barclays analyst Hassan Al-Wakeel said in a note. In May, the Amsterdam-listed company lowered its profitability outlook for the year by 100 basis points, blaming the cost of dealing with tariffs and estimating a hit of as much as €300 million. It now sees an impact of as much as €200 million. On Sunday, the European Union reached a deal with the US with Brussels accepting a 15% tariff on most of its exports, dodging an imminent trade war. More than 40% of Philips' sales are in the US with a third of production inside the country. Philips is asking for tariff exemptions for the healthcare sector. 'The US is a very important market for us,' Jakobs said in an interview with Bloomberg TV, adding that the company is expanding its presence and investment there. Philips's stock was down 19% in the year before Tuesday as the company suffered a string of setbacks. A settlement last year over a 2021 recall of faulty sleep apnea devices made way for sluggish growth in China and an expected hit from the trade war. Since taking the helm at Philips in October 2022, Jakobs has cut jobs, revamped leadership and simplified operations. He is emphasizing patient safety and developing new products, with the company spending more than 9% of sales on innovation last year. Still, headwinds such as weak consumer sentiment in China and the implementation of anti-graft measures for its health care sector have dampened demand. Sales in China declined again in the second quarter, but were offset by growth in India and Latin America. Philips' comparable orders increased 6% in the second quarter, up from 2% in the previous three months. The company said Tuesday it signed an agreement with Indonesia for its Azurion image-guided therapy system. The multi-year deal is worth hundreds of millions of euros, according to a person familiar, who asked not to be identified discussing private information. The company also increased its free cash flow outlook to between €200 million and €400 million, from 'slightly positive' before. --With assistance from Lisa Pham, Sarah Jacob, Anna Edwards, Kriti Gupta and Guy Johnson. (Updates with share move in second paragraph.) More stories like this are available on
The Sun
29-07-2025
- Business
- The Sun
Philips cuts tariff impact by 100 million euros after US-EU deal
AMSTERDAM: Dutch healthcare giant Philips has lowered its estimated financial impact from U.S. import tariffs by 100 million euros following a trade agreement between the U.S. and the European Union. The company now expects tariffs to cost between 150-200 million euros this year, down from its earlier forecast of 250-300 million euros. Philips CEO Roy Jakobs stated that the U.S.-EU deal provided 'clarity' but emphasized the company would continue pushing for exemptions for the healthcare sector. 'The tariff impact has evolved and continues to be dynamic,' Philips said in a statement. The company's Amsterdam-listed shares were projected to rise 4-5% in early trading. Philips also raised its full-year core profit (EBITA) margin forecast to 11.3-11.8%, up from 10.8-11.3%, after reporting a stronger-than-expected second-quarter adjusted EBITA margin of 12.4%. Despite trade tensions, Philips remains resilient in key markets. Jakobs noted that 90% of its products sold in China are locally manufactured, minimizing the impact of Beijing's recent restrictions on EU medical device purchases. 'The Chinese market is slowly recovering,' he added. The company also secured a long-term agreement with Indonesia's Ministry of Health for its Azurion image-guided therapy system, reinforcing its presence in Asia. - Reuters
Toronto Star
29-07-2025
- Health
- Toronto Star
Indonesia's Ministry of Health and Philips to deliver nationwide coverage of advanced image-guided therapy systems in Indonesia, expanding access to cardiac, stroke and cancer care in all 38 provinces
Long-term multiyear agreements will see Philips installing its advanced Azurion image-guided therapy systems nationwide across all provinces, including rural and remote areas Initiative brings minimally invasive care to millions of cardiac, stroke and cancer patients in Indonesia Combines cutting-edge treatment technology, services and training to strengthen Indonesia's health infrastructure
